- Home
- BATL vs PASG Comparison
BATL vs PASG Comparison
Compare BATL & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- PASG
- Stock Information
- Founded
- BATL 1987
- PASG 2017
- Country
- BATL United States
- PASG United States
- Employees
- BATL N/A
- PASG N/A
- Industry
- BATL Oil & Gas Production
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- BATL Energy
- PASG Health Care
- Exchange
- BATL Nasdaq
- PASG Nasdaq
- Market Cap
- BATL 109.4M
- PASG 42.2M
- IPO Year
- BATL N/A
- PASG 2020
- Fundamental
- Price
- BATL $6.62
- PASG $0.60
- Analyst Decision
- BATL
- PASG Strong Buy
- Analyst Count
- BATL 0
- PASG 2
- Target Price
- BATL N/A
- PASG $9.00
- AVG Volume (30 Days)
- BATL 124.5K
- PASG 256.8K
- Earning Date
- BATL 11-13-2024
- PASG 11-11-2024
- Dividend Yield
- BATL N/A
- PASG N/A
- EPS Growth
- BATL N/A
- PASG N/A
- EPS
- BATL N/A
- PASG N/A
- Revenue
- BATL $200,322,000.00
- PASG N/A
- Revenue This Year
- BATL $2.21
- PASG N/A
- Revenue Next Year
- BATL N/A
- PASG N/A
- P/E Ratio
- BATL N/A
- PASG N/A
- Revenue Growth
- BATL N/A
- PASG N/A
- 52 Week Low
- BATL $2.48
- PASG $0.54
- 52 Week High
- BATL $9.69
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- BATL 74.88
- PASG 42.21
- Support Level
- BATL $6.60
- PASG $0.56
- Resistance Level
- BATL $6.71
- PASG $0.63
- Average True Range (ATR)
- BATL 0.08
- PASG 0.08
- MACD
- BATL -0.11
- PASG 0.00
- Stochastic Oscillator
- BATL 50.00
- PASG 31.11
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent oil and gas producer operating exclusively in the Delaware Basin. It is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the United States. The company operates in one segment which focuses on oil and natural gas acquisition, production, exploration, and development.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.